Humana Inc. HUM
Composite 53/100; the shares have moved about 41% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.
Growth ranks 37/100 — a moderate mark against it.
Momentum ranks 78/100 — a strong point in its favour. Balance-sheet strength ranks 70/100 — a moderate point in its favour.
Growth ranks 37/100 — a moderate mark against it. Quality ranks 40/100 — a slight mark against it. Income ranks 43/100 — a slight mark against it.
What the company does Humana Inc. (HUM) operates in the U.S. healthcare insurance and senior-focused care services, offering Medicare Advantage, prescription drug plans, dental, vision, life insurance, and primary care centers under CenterWell.
Key financials Humana reports ROE 7%, ROA 4%, and ROCE 7%, with net margins at 1% and revenue/EPS growth of 26%/27%. Debt/Equity is 0.76, interest coverage 3.3x, and current ratio 1.74. Valuation metrics include P/E 34.35 (forward 40), P/B 2.26, and FCF yield 4%.
Stock health Sideravia scores Humana at 56 overall (Quality 31, Growth 46, Momentum 81). Momentum is strong: +56% over 3 months, +100% over 6 months, but down 10% from its 52-week high. RSI(14) sits at 54.
Price vs fair value HUM trades at a **discount of 7.30%** to the analyst mean target of 413.09. - Q2 2026 EPS outlook cut despite strong results and buybacks (Simply Wall St.) - Peer comparisons highlight margin pressures vs. UNH (Trefis) - CVS’s 2027 guidance miss weighed on managed-care sentiment (Bloomberg)
Looking forward Forward P/E of 40x reflects growth expectations in Medicare Advantage and CenterWell’s primary care expansion, offset by margin pressures noted in recent earnings commentary.
This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.
Data as of 2026-09-04, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.